Venclose is a Commercial-stage Silicon Valley medical technology company developing next-generation solutions for the treatment of venous reflux disease, also known as chronic venous insufficiency (CVI). CVI is a progressive medical condition affecting more than 40 million adults in the United States alone. The VENCLOSE RF Ablation System offers physicians more versatility than earlier generation endovenous radiofrequency ablation technologies and is commercially available in the United States and Europe.
Realized – sold to Becton Dickinson November 2021
OrthoFX reimagines the approach to the end-to-end clear aligner experience through quality face-to-face doctor care, clear cut pricing and trusted results. OrthoFX is the first company to offer the convenience of comfortable, clear aligners designed through a proprietary material - FXTetra aligner- which delivers 50% faster treatment. From the beginning of the straightening journey, OrthoFX provides a frictionless experience that is fun and supports patients every step along the way.
Neptune Medical is the developer of a novel gastroenterology technology designed to assist in diagnosis and treatment of diseases of the small intestine. The company's platform has developed three separate product concepts to assist in navigation, guidance and imaging, enabling doctors to improve the treatment of gastrointestinal disease.
iDentical, Inc. is a California-based developer of personalized dental implants focused on disrupting the current tooth replacement paradigm with drill-free dental implants. iDentical’s goal is to preserve native bone structures while shortening overall procedure times for tooth extraction and replacement. iDentical’s drill-free implant systems are aimed at giving general dentists the tools to perform this less invasive procedure while allowing for better overall patient satisfaction.
Inhalon Biopharma, Inc – Inhalon Biopharma is a startup immunotherapy company developing an inhaled antibody platform for treating a variety of acute respiratory infections. The Company’s intellectual property includes multiple approved U.S. and EU patents broadly covering the composition and use of aerosolized antibodies, licensed from The University of North Carolina at Chapel Hill and Johns Hopkins University.
CrossLiner, Inc. – CrossLiner is developing next generation guide catheter extension products to assist cardiologists to better care for their patients. The GuideLiner product is the Company’s first guide extension device to enable deliver of balloon catheters and stents when additional guide support is required.
Avenda Health, Inc. – Avenda Health is developing AI software combined with novel hardware to transform whole gland prostate cancer therapy in a patient specific treatment that preserves quality of life, via a simple ablative therapy performed in a doctor’s office using local anesthesia. Avenda utilizes AI with existing imaging and pathology to precisely target cancer margins while avoiding critical structures.
Hart Dairy has redefined the grass-fed dairy standard through its production of premium “Grass 365” dairy products, including fresh milk, yogurt, cheese and butter varieties. Located near Augusta, Georgia, Hart Dairy sits on more than 4,000 acres of pristine farmland and is the largest single-source producer of 100% free-range, grass-fed milk in North America. Hart Dairy passionately combines animal welfare and better-for-you dairy products with truly free-range, grass-fed cows.
EV Connect - EV Connect is on a mission to build a better planet by enabling electricity as a transportation fuel. Through its innovative and open charging cloud platform, EV Connect simplifies the set-up, management, and optimization of charging services with premium customer support, from installation to the driver experience. EV Connect guides companies of
all sizes in managing networks of chargers and delivers a seamless EV charging experience that empowers drivers.
